Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2022-08-16 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '한국비엔씨' (BNC Korea Co., Ltd.) covering the period from January 1, 2022, to June 30, 2022. It contains detailed corporate information, business descriptions, capital structure, and financial data, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
파생상품거래손실발생
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure from a Korean company (한국비엔씨) regarding a 'Loss from Derivative Transactions' (파생상품거래손실발생). This is a specific type of material event disclosure required by financial regulators. Since it does not fit into categories like earnings releases, dividends, or board changes, and is a formal regulatory filing regarding financial impact, it falls under the 'Regulatory Filings' (RNS) category.
2022-08-16 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'BNC Korea Co., Ltd.' (주식회사 한국비엔씨) for the period from January 1, 2022, to March 31, 2022. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
파생상품거래손실발생
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure from a Korean company (한국비엔씨) regarding a 'Loss from Derivative Transactions' (파생상품거래손실발생). It details the nature of the loss, the financial impact relative to equity, and the accounting reasons (K-IFRS valuation of convertible bonds/preferred shares). Since this is a specific regulatory disclosure of a material event that does not fit into financial reports, earnings releases, or other specific categories, it is classified as a general regulatory filing.
2022-05-16 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a formal regulatory filing from a Korean company (한국비엔씨) announcing the acquisition of shares in another company (타법인주식및출자증권취득결정). This type of disclosure, which details the acquisition of equity in another entity, the purpose of the acquisition, and financial summaries of the target company, falls under M&A activity (Mergers and Acquisitions).
2022-05-13 Korean
신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure regarding a new facility investment (capital expenditure) by the company. It details the investment amount, purpose, timeline, and board approval status. Since it relates to a specific corporate capital investment project rather than a general financing update or share issuance, and does not fit into the other specific categories, it is classified as a general regulatory filing.
2022-04-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.